Why the study?
Does a combined IV and SC insulin strategy reduce surgical morbidity and mortality in diabetic patients undergoing cardiac surgery?
Does a combined IV and SC insulin strategy reduce surgical morbidity and mortality in diabetic patients undergoing cardiac surgery?
A combined IV and SC insulin strategy is a less costly and less nursing-intensive alternative that reduces surgical morbidity and mortality in diabetic patients after cardiac surgery.
May support combined insulin strategies in diabetic cardiac surgery patients; hypothesis-generating and requires randomized confirmation.
A combination of IV insulin (in the ICU) and SC insulin (outside the ICU), a less costly and less nursing-intensive therapy than 3 days of IV insulin postoperatively, results in a reduction of the increased surgical morbidity and mortality in diabetic patients after CT surgery.
No takes yet. Share an insight, caveat, or question.
Schmeltz et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: